FAT1 and cancer: It is worth noticing that the number of cancer samples with SHANK2 amplifications way exceeds those with YAP1 amplification, FAT1 deletion, and NF2 deletion (Figures 1B, 2), indicating a previously unnoticed role of SHANK2 as a major oncogene.